491 related articles for article (PubMed ID: 21098287)
21. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation.
Zhang Y; Fan X; Su Z; Yuan T; Yin H; Gu H; Zuo Y; Chen S; Zhou H; Su G
Environ Toxicol; 2021 Dec; 36(12):2414-2425. PubMed ID: 34432352
[TBL] [Abstract][Full Text] [Related]
23. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
Deters N; Ittner LM; Götz J
Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
[TBL] [Abstract][Full Text] [Related]
24. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
Gratuze M; Julien J; Petry FR; Morin F; Planel E
Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
[TBL] [Abstract][Full Text] [Related]
25. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
Planel E; Yasutake K; Fujita SC; Ishiguro K
J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
[TBL] [Abstract][Full Text] [Related]
27. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.
Li J; Deng J; Sheng W; Zuo Z
Pharmacol Biochem Behav; 2012 Jun; 101(4):564-74. PubMed ID: 22425595
[TBL] [Abstract][Full Text] [Related]
28. Galpha12 directly interacts with PP2A: evidence FOR Galpha12-stimulated PP2A phosphatase activity and dephosphorylation of microtubule-associated protein, tau.
Zhu D; Kosik KS; Meigs TE; Yanamadala V; Denker BM
J Biol Chem; 2004 Dec; 279(53):54983-6. PubMed ID: 15525651
[TBL] [Abstract][Full Text] [Related]
29. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice.
Kins S; Crameri A; Evans DR; Hemmings BA; Nitsch RM; Gotz J
J Biol Chem; 2001 Oct; 276(41):38193-200. PubMed ID: 11473109
[TBL] [Abstract][Full Text] [Related]
30. Nmnat2 attenuates Tau phosphorylation through activation of PP2A.
Cheng XS; Zhao KP; Jiang X; Du LL; Li XH; Ma ZW; Yao J; Luo Y; Duan DX; Wang JZ; Zhou XW
J Alzheimers Dis; 2013; 36(1):185-95. PubMed ID: 23579329
[TBL] [Abstract][Full Text] [Related]
31. Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.
Landrieu I; Smet-Nocca C; Amniai L; Louis JV; Wieruszeski JM; Goris J; Janssens V; Lippens G
PLoS One; 2011; 6(6):e21521. PubMed ID: 21731772
[TBL] [Abstract][Full Text] [Related]
32. A new paradigm for regulation of protein phosphatase 2A function via Src and Fyn kinase-mediated tyrosine phosphorylation.
Sontag JM; Schuhmacher D; Taleski G; Jordan A; Khan S; Hoffman A; Gomez RJ; Mazalouskas MD; Hanks SK; Spiller BW; Sontag E; Wadzinski BE
J Biol Chem; 2022 Aug; 298(8):102248. PubMed ID: 35820485
[TBL] [Abstract][Full Text] [Related]
33. mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A.
Harwood FC; Shu L; Houghton PJ
J Biol Chem; 2008 Feb; 283(5):2575-85. PubMed ID: 18056704
[TBL] [Abstract][Full Text] [Related]
34. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
35. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
[TBL] [Abstract][Full Text] [Related]
36. Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice.
Kins S; Kurosinski P; Nitsch RM; Götz J
Am J Pathol; 2003 Sep; 163(3):833-43. PubMed ID: 12937125
[TBL] [Abstract][Full Text] [Related]
37. Role of protein phosphatase 2A in Alzheimer's disease.
Rudrabhatla P; Pant HC
Curr Alzheimer Res; 2011 Sep; 8(6):623-32. PubMed ID: 21605044
[TBL] [Abstract][Full Text] [Related]
38. High-glucose-induced apoptosis, ROS production and pro-inflammatory response in cardiomyocytes is attenuated by metformin treatment via PP2A activation.
Cheng G; Li L
J Biosci; 2020; 45():. PubMed ID: 33184242
[TBL] [Abstract][Full Text] [Related]
39. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.
Rametti A; Esclaire F; Yardin C; Terro F
J Biol Chem; 2004 Dec; 279(52):54518-28. PubMed ID: 15475565
[TBL] [Abstract][Full Text] [Related]
40. Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.
Liang Z; Liu F; Iqbal K; Grundke-Iqbal I; Wegiel J; Gong CX
J Alzheimers Dis; 2008 Apr; 13(3):295-302. PubMed ID: 18430997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
